Echo Therapeutics (ECTE) Reports In-Line Q2 Loss of 6c/Share
Tweet
Share
E-mailGet Alerts ECTE Hot Sheet
Join SI Premium – FREE
Echo Therapeutics (NASDAQ: ECTE) reported Q2 loss of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $121.46 thousand versus the consensus estimate of $100 thousand.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- FGI Industries Ltd (FGI) Tops Q2 EPS by 59c
- EquipmentShare.com Inc. (EQPT) Reports Q2 EPS of $0.18; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
